1st Quarter - Report

VENABLE LLP for DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues related to neglected diseases research and development and access; COVID treatments research and development; S. 3799 - PREVENT Pandemics Act.

LobbyistCovered position, as disclosed
JODIE CURTIS —

Bills named: S. 3799 (117th)

Budget/Appropriations BUD

FY 2022 and FY 2023 Labor, Health and Human Services, Education, and State and Foreign Operations funding for global health research and development and neglected tropical diseases and covid treatments; Issues related to global health.

LobbyistCovered position, as disclosed
JODIE CURTIS —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.